Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, Susana Riesco et al.|British Journal of Cancer|2017Cited by 51
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidRicardo Sánchez, Joaquín Martínez‐López, Rosa Ayala et al.|Annals of Hematology|2017Cited by 30
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristicsRicardo Sánchez, Joaquín Martínez‐López, Jordi Ribera et al.|Blood Cancer Journal|2020Cited by 23
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNARicardo Sánchez, Joaquín Martínez‐López, Sara Dorado et al.|Scientific Reports|2022Cited by 12
Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/<i>TCF3‐PBX1</i> treated with measurable residual disease‐oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades et al.|British Journal of Haematology|2021Cited by 7